Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

CD300f:IL-5 cross-talk inhibits adipose tissue eosinophil homing and subsequent IL-4 production.

Rozenberg P, Reichman H, Zab-Bar I, Itan M, Pasmanik-Chor M, Bouffi C, Qimron U, Bachelet I, Fulkerson PC, Rothenberg ME, Munitz A.

Sci Rep. 2017 Jul 19;7(1):5922. doi: 10.1038/s41598-017-06397-4.

2.

CD300f associates with IL-4 receptor α and amplifies IL-4-induced immune cell responses.

Moshkovits I, Karo-Atar D, Itan M, Reichman H, Rozenberg P, Morgenstern-Ben-Baruch N, Shik D, Ejarque-Ortiz A, Hershko AY, Tian L, Coligan JE, Sayós J, Munitz A.

Proc Natl Acad Sci U S A. 2015 Jul 14;112(28):8708-13. doi: 10.1073/pnas.1507625112. Epub 2015 Jun 29.

3.

Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis.

Wu D, Molofsky AB, Liang HE, Ricardo-Gonzalez RR, Jouihan HA, Bando JK, Chawla A, Locksley RM.

Science. 2011 Apr 8;332(6026):243-7. doi: 10.1126/science.1201475. Epub 2011 Mar 24.

4.

A key requirement for CD300f in innate immune responses of eosinophils in colitis.

Moshkovits I, Reichman H, Karo-Atar D, Rozenberg P, Zigmond E, Haberman Y, Ben Baruch-Morgenstern N, Lampinen M, Carlson M, Itan M, Denson LA, Varol C, Munitz A.

Mucosal Immunol. 2017 Jan;10(1):172-183. doi: 10.1038/mi.2016.37. Epub 2016 Apr 27.

PMID:
27118491
5.

CCR2 deficiency leads to increased eosinophils, alternative macrophage activation, and type 2 cytokine expression in adipose tissue.

Bolus WR, Gutierrez DA, Kennedy AJ, Anderson-Baucum EK, Hasty AH.

J Leukoc Biol. 2015 Oct;98(4):467-77. doi: 10.1189/jlb.3HI0115-018R. Epub 2015 May 1.

6.

CMRF35-like molecule 1 (CLM-1) regulates eosinophil homeostasis by suppressing cellular chemotaxis.

Moshkovits I, Shik D, Itan M, Karo-Atar D, Bernshtein B, Hershko AY, van Lookeren Campagne M, Munitz A.

Mucosal Immunol. 2014 Mar;7(2):292-303. doi: 10.1038/mi.2013.47. Epub 2013 Jul 3.

PMID:
23820751
7.

Paired immunoglobulin-like receptor A is an intrinsic, self-limiting suppressor of IL-5-induced eosinophil development.

Ben Baruch-Morgenstern N, Shik D, Moshkovits I, Itan M, Karo-Atar D, Bouffi C, Fulkerson P, Rashkovan D, Jung S, Rothenberg ME, Munitz A.

Nat Immunol. 2014 Jan;15(1):36-44. doi: 10.1038/ni.2757. Epub 2013 Nov 10.

8.

Helminth antigens counteract a rapid high-fat diet-induced decrease in adipose tissue eosinophils.

van den Berg SM, van Dam AD, Kusters PJH, Beckers L, den Toom M, van der Velden S, Van den Bossche J, van Die I, Boon MR, Rensen PCN, Lutgens E, de Winther MPJ.

J Mol Endocrinol. 2017 Oct;59(3):245-255. doi: 10.1530/JME-17-0112. Epub 2017 Jul 10.

PMID:
28694301
9.

Interleukin-5, interleukin-3, and granulocyte-macrophage colony-stimulating factor cross-compete for binding to cell surface receptors on human eosinophils.

Lopez AF, Vadas MA, Woodcock JM, Milton SE, Lewis A, Elliott MJ, Gillis D, Ireland R, Olwell E, Park LS.

J Biol Chem. 1991 Dec 25;266(36):24741-7.

10.

Interferon-gamma enhances human eosinophil effector functions induced by granulocyte-macrophage colony-stimulating factor or interleukin-5.

Yamaguchi T, Kimura H, Kurabayashi M, Kozawa K, Kato M.

Immunol Lett. 2008 Jun 15;118(1):88-95. doi: 10.1016/j.imlet.2008.03.005. Epub 2008 Apr 10.

PMID:
18440651
11.

Stromal cell cadherin-11 regulates adipose tissue inflammation and diabetes.

Chang SK, Kohlgruber AC, Mizoguchi F, Michelet X, Wolf BJ, Wei K, Lee PY, Lynch L, Duquette D, Ceperuelo-Mallafré V, Banks AS, Brenner MB.

J Clin Invest. 2017 Sep 1;127(9):3300-3312. doi: 10.1172/JCI86881. Epub 2017 Jul 31.

12.

In vivo administration of antibody to murine IL-5 receptor inhibits eosinophilia of IL-5 transgenic mice.

Hitoshi Y, Yamaguchi N, Korenaga M, Mita S, Tominaga A, Takatsu K.

Int Immunol. 1991 Feb;3(2):135-9.

PMID:
2025613
13.

Licochalcone F alleviates glucose tolerance and chronic inflammation in diet-induced obese mice through Akt and p38 MAPK.

Bak EJ, Choi KC, Jang S, Woo GH, Yoon HG, Na Y, Yoo YJ, Lee Y, Jeong Y, Cha JH.

Clin Nutr. 2016 Apr;35(2):414-421. doi: 10.1016/j.clnu.2015.03.005. Epub 2015 Mar 16.

PMID:
25823386
14.

[Growth and differentiation of eosinophils--special reference to IL-5 and its receptor].

Akutsu I, Takatsu K.

Nihon Rinsho. 1993 Mar;51(3):557-64. Review. Japanese.

PMID:
8492427
15.

Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages.

Molofsky AB, Nussbaum JC, Liang HE, Van Dyken SJ, Cheng LE, Mohapatra A, Chawla A, Locksley RM.

J Exp Med. 2013 Mar 11;210(3):535-49. doi: 10.1084/jem.20121964. Epub 2013 Feb 18.

16.

[Characterization of a receptor for interleukin-5 on pulmonary eosinophils with eosinophilic pneumonia].

Chihara J, Nakajima S.

Nihon Kyobu Shikkan Gakkai Zasshi. 1992 Dec;30 Suppl:70-6. Japanese.

PMID:
1306241
17.

Apoptosis inhibitor of macrophage (AIM) is required for obesity-associated recruitment of inflammatory macrophages into adipose tissue.

Kurokawa J, Nagano H, Ohara O, Kubota N, Kadowaki T, Arai S, Miyazaki T.

Proc Natl Acad Sci U S A. 2011 Jul 19;108(29):12072-7. doi: 10.1073/pnas.1101841108. Epub 2011 Jul 5.

18.

Interleukin-33 requires CMRF35-like molecule-1 expression for induction of myeloid cell activation.

Shik D, Moshkovits I, Karo-Atar D, Reichman H, Munitz A.

Allergy. 2014 Jun;69(6):719-29. doi: 10.1111/all.12388. Epub 2014 Apr 15.

PMID:
24735452
20.

A dual activation and inhibition role for the paired immunoglobulin-like receptor B in eosinophils.

Munitz A, McBride ML, Bernstein JS, Rothenberg ME.

Blood. 2008 Jun 15;111(12):5694-703. doi: 10.1182/blood-2007-12-126748. Epub 2008 Mar 3.

Supplemental Content

Support Center